Feeling hot on Wegovy: what the warmth means and what to do

Flushing and warmth are recognised, listed side effects of semaglutide (Wegovy), most common shortly after a dose change.
GLP-1 receptor agonists like Wegovy influence blood vessels and digestion in ways that can temporarily raise skin temperature or trigger hot flushes.
Most people find this settles as their body adjusts, usually within days to two weeks at a given dose level.
Severe, persistent heat alongside other symptoms — particularly strong abdominal pain — needs prompt medical attention.

Feeling hot, flushed or unusually warm after a Wegovy dose is something many people notice, particularly in the first few weeks of treatment. It is generally a recognised side effect linked to how semaglutide affects your body's systems, not a sign that something has gone wrong. Here is what the evidence tells us, and the moments when it is worth seeking advice.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the warmth actually means, when it fades, and the signs that need a second opinion

You've just taken your Wegovy pen and now you feel strangely warm

Picture the scene: you've done your weekly injection, carried on with your morning, and an hour or two later there's an odd flush across your face or chest. Maybe your skin feels hot to touch. You check whether you're coming down with something, and decide you probably aren't. Then it fades. If that sounds familiar, you are far from alone.

The warmth most people describe is a vasodilatory effect, semaglutide acts on GLP-1 receptors found not just in the gut but in blood vessels throughout the body. When those receptors are activated, blood vessels can briefly widen, letting more blood reach the skin's surface. The result is the sensation of heat, redness, or a mild flush, without any underlying infection or fever. The NHS medicines page for semaglutide lists flushing among the known side effects of the drug, so this is a documented, expected reaction rather than an anomaly.

The timing matters, too. Sensations tend to peak in the hours after an injection and are most noticeable after starting treatment or stepping up to a new dose. If you are curious about the broader arc of how and when Wegovy's effects make themselves felt, the page on when Wegovy starts to take effect sets that timeline out clearly.

Why dose increases seem to bring it back

One thing patients often tell us they wish they had known earlier: flushing that settled at 0.5mg or 1.0mg can reappear when the dose steps up to 1.7mg or 2.4mg. This is not a sign of intolerance or that the medicine has suddenly stopped agreeing with you. The body simply goes through a fresh adjustment period at each new level.

The GI side effects of Wegovy (nausea, bloating, changes in digestion) follow the same pattern, and the hotness or flushing often travels with them. Some people notice the warmth is worse if they are also dealing with bloating on Wegovy, which can accompany slowed gastric emptying. Others find it appears in isolation.

Staying well hydrated helps more than most people expect. When you are warm and your digestive system is working differently, fluid intake can slip without you noticing. Practical steps that tend to help: keep cool water nearby, avoid sitting in a hot room immediately after your injection, and give yourself a quieter hour if your schedule allows.

There is a common misconception that feeling hot means Wegovy is raising your core body temperature, or that you should pause treatment. Neither is supported by the evidence. The flush is a surface event. Your internal temperature is not climbing, and the feeling passes.

When the heat is something to take seriously

Most flushing is benign and self-limiting. There are situations, though, where warmth is a secondary signal pointing to something that needs attention.

Severe nausea or vomiting alongside intense warmth and dizziness can indicate dehydration, particularly if you have not been keeping fluids down. The dizziness page covers the fluid-and-blood-pressure connection in more detail, but the short version is: dehydration from GI illness can compound quickly on a GLP-1 medicine, and you should contact your GP or 111 if you cannot hold fluids down for more than a few hours.

More urgently: if the warmth comes alongside severe, persistent stomach pain that spreads towards your back, seek medical attention promptly. In January 2026, the MHRA issued a Drug Safety Update specifically about acute pancreatitis as an infrequent but serious side effect of GLP-1 medicines, including semaglutide. The symptom signature it flagged was exactly that, strong abdominal pain, sometimes with vomiting, that does not ease. You can report any suspected side effects directly through the MHRA Yellow Card scheme.

Signs of an allergic reaction (widespread rash, swelling of the face or throat, or difficulty breathing alongside the heat) also warrant emergency care rather than watchful waiting.

Getting clinical support if the flushing is affecting you

If warmth or flushing is manageable but persistent, it is genuinely worth mentioning at your next clinical review rather than simply tolerating it. A prescriber can look at whether the titration pace suits you, whether anything in your routine is compounding the effect, and whether the pattern changes how your care is managed going forward. For context on the treatment's wider cost and what clinical review looks like as part of a private prescription service, the Wegovy cost page explains what ongoing support should include.

If you want to understand more about how Wegovy works before or alongside treatment, the Wegovy overview and the broader semaglutide guide cover the mechanism and evidence in fuller detail. And if you are experiencing other physical changes that feel unusual (like an unexpected drop in body temperature rather than a rise) the page on feeling cold on Wegovy is also worth a read, since both ends of the temperature spectrum can appear as the body adjusts.

If something does not feel right, or you are unsure whether what you are experiencing is expected, speak to our prescribers. A clinician who knows your history can give you a far more grounded answer than any general article.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions